| Document Date: 2014-10-23 02:08:58
Open Document File Size: 294,34 KBShare Result on Facebook
City SECB / / Company Amp / / Country United Kingdom / / / Event Product Issues / / IndustryTerm primer binding site / multi-component systems / / MedicalCondition feline leukemia virus / tumor / leukemia virus / Moloney murine leukemia virus / pBR gag-pol-env Infectious RNA / Herpes / ecotropic murine leukemia viruses / Infection / defective Infection / Gibbon ape leukemia virus / vesicular stomatitis virus / infectious particles / / MedicalTreatment gene therapy / / NaturalFeature Semliki forest / / Organization Swiss Expert Committee for Biosafety SECB / Biosafety SECB c/o Federal Office for the Environment FOEN / / Person Van den Driessche / / / Position Governor / Safety Executive / / Product ampicillin / ecotropic retroviruses / retroviral and lentiviral vectors / ecotropic murine retroviruses / amphotropic vectors / adenovirus genome / gene / lentiviral vectors containing envelope proteins / ecotropic vectors / Infection / retroviral vectors containing envelope proteins / murine amphotropic retroviruses / viruses / subgenomic / lentiviral vectors / / Technology gene therapy / recombination / pdf / / URL http /
SocialTag |
Recommendation of the SECB on the classification of work with genetically modified viral vectors December[removed]updated September[removed]Swiss Expert Committee for Biosafety SECB